NCT Number: NCT01365949
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research trial studies biomarkers in tissue samples from patients with Ewing sarcoma.
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 120 year
Sex eligibility
All sexes
Study type
Observational
About this study
OBJECTIVES:
- To determine the frequency of INI-1 protein loss in Ewing Sarcoma.
OUTLINE: Previously collected tissue samples are analyzed for INI-1 protein loss by IHC and tissue microarray.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Diagnosis of Ewing sarcoma
- Prepared tissue microarray with Ewing sarcoma samples available
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
protein analysis
Geneticimmunohistochemistry staining method
Otherlaboratory biomarker analysis
OtherPrimary outcomes
-
Frequency of INI1 protein loss in Ewing Sarcoma
Sponsors and collaborators
Lead sponsor
Children's Oncology Group
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
INI-1 Deletions in Ewing Sarcoma
Important dates
- Study start
- 2011
- Primary completion
- 2016
- First posted
- Jun 3, 2011
- Registry last updated
- Jul 11, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
NCT00445965
Adnexal Diseases, Astrocytoma
New York, United States
View Trial DetailsPbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
NCT02736565
Bone Diseases, Bone Neoplasms
New York, United States
View Trial DetailsComparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
NCT00006734
Neoplasms, Neoplasms by Histologic Type
Birmingham, Alabama, United States
View Trial DetailsRadiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
NCT00003308
Adenocarcinoma, Adnexal Diseases
Des Moines, Iowa, United States
View Trial Details